Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults

Clinical trial NCT04824872 · WITHDRAWN

Trial details

NCT number: NCT04824872
Sponsor: Zealand Pharma
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hypoglycemia Glucose Metabolism Disorders

Start date: 2023-02-01
Primary completion: 2023-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.